4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-22-027883
Chief Financial Officer sold 5,700 shares at $10.90 ($62,130)
From the SEC's structured data for this filing
Trades in this filing
Doyle Anthony · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-12-15 | Sale : show line 1 in the form | −5,700 | $10.90 | $62,130 | 163,966 | D |
| Open-market sales · 5,700 sh · avg $10.90 · $62,130 | ||||||
Loading xslF345X03/form4.xml…